Skip to main content

Client News

AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer

6th September 2023

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine

6th September 2023

Element Materials unveils fully integrated pharma services platform, strengthening its expanding Life Sciences Division

5th September 2023

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding

5th September 2023

Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market

5th September 2023

iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer

5th September 2023

InflaRx’s Marketing Authorization Application (MAA) for Vilobelimab for Treatment of Critically Ill COVID-19 Patients under Review by European Medicines Agency (EMA)

30th August 2023

Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations

23rd August 2023

AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication

23rd August 2023

Medigene AG Expands Intellectual Property Rights for its Costimulatory Switch Proteins to Additional Immune Cell Types

23rd August 2023